Collagen Solutions reports its US research and development consolidation is “on track” to merge into a new facility in near Minneapolis next month and recent business wins will underpin growth in the second-half.

The Glasgow headquartered group said the US consolidation, which will relocate the San Jose research and development (R&D) headquarters move to Minnesota, will improve collaboration and deliver cost-savings to fund further R&D investment.

Read More

Chief executive Jamal Rushdy will tell shareholder at the company's annual general meeting in Glasgow that Collagen Solutions has now enrolled 12 of the 15 patients for an open label extension study for its knee cartilage repair product, ChondroMimetic.

Rushdy said: “We expect final data collection and analysis by the end of the calendar year, with a submission for CE-mark certification to follow.”

Collagen Solutions notes it has also strengthened its tissue business, having recently expanded abattoir capacity “by approximately 80 per cent”, and additional abattoir qualifications and yield improvement initiatives “are in process”.

Rushdy will tell shareholders: “Our core business momentum is continuing with four new early-stage customer deals in the first quarter of the fiscal year, including two new tissue customers.

“This new business will help underpin our overall anticipated growth which is weighted to the second half of our fiscal year.”

Collagen Solutions was launched in 2008 as a subsidiary of sausage skin maker Devro to exploit biomedical applications for medical grade collagen.

In 2011 the assets were sold to Angel Biotechnology Holdings Plc, which was placed into administration in 2013.

In 2013 co-founder and former chief scientific officer Dr Stewart White secured backing for a new venture, Collbio from life sciences investment firm Diagnostic Capital to acquire the collagen assets of Angel Biomedical Ltd.

Read More

Collbio Ltd then acquired California-based Collagen Solutions LLC in late 2013 and followed up with a reverse listing on the London AIM market in January 2014 which saw Collbio renamed Collagen Solutions Plc.

Dr White left Collagen Solutions in April of this year to “pursue other opportunities”.